Target Name: SLC39A4
NCBI ID: G55630
Other Name(s): solute carrier family 39 member 4 | Solute carrier family 39 member 4 | S39A4_HUMAN | Acrodermatitis enteropathica, zinc-deficiency type | Zrt- and Irt-like protein 4 | ZIP-4 | Solute carrier family 39 member 4, transcript variant 1 | ZRT/IRT-like protein 4 | solute carrier family 39 (zinc transporter), member 4 | AWMS2 | Zinc transporter ZIP4 | Zinc transporter ZIP4 isoform 1 | zrt- and Irt-like protein 4 | zinc transporter 4 | SLC39A4 variant 2 | SLC39A4 variant 1 | Solute carrier family 39 member 4, transcript variant 2 | Zinc transporter ZIP4 isoform 2 precursor (isoform 2) | AEZ | ZIP4

SLC39A4: A Potential Drug Target Or Biomarker

SLC39A4, also known as SLC39A4 gene, is a member of the SLC39 family which is a well-known transmembrane protein family that plays an important role in various physiological processes in the body. SLC39A4 is a protein that is expressed in various tissues of the body including brain, heart, and blood vessels.

SLC39A4 is a protein that is involved in the transport of various substances including ions, nutrients, and medications across the membrane of cells. It is a transmembrane protein which means that it spans the membrane of the cell and is responsible for regulating the movement of substances into and out of the cell.

One of the unique features of SLC39A4 is its structure. It has a unique transmembrane domain which is responsible for its unique structure and function. The transmembrane domain is made up of multiple domains including an N-terminus, a T-terminus, and a middle domain. The N-terminus is responsible for the protein's ability to interact with various signaling molecules, the T-terminus is responsible for the protein's ability to interact with various substrates, and the middle domain is responsible for the protein's ability to transport various substances across the membrane.

SLC39A4 is a protein that has been shown to be involved in various signaling pathways in the body. One of the well-known signaling pathways that SLC39A4 is involved in is the regulation of ion transport. SLC39A4 is a protein that is involved in the regulation of the movement of positively charged ions (Na+) and negatively charged ions (Cl-) across the membrane of cells. This is important for maintaining the proper balance of ions in the body which is essential for various physiological processes.

Another signaling pathway that SLC39A4 is involved in is the regulation of cell adhesion. SLC39A4 is a protein that is involved in the regulation of the stickiness of cells to various adhesion molecules. This is important for the maintenance of tissue structure and the development and maintenance of various tissues in the body.

SLC39A4 is also involved in the regulation of various signaling pathways that are important for the development and maintenance of the brain. This includes the regulation of neurotransmitter release, neurogenesis, and the regulation of synaptic plasticity. SLC39A4 is a protein that is involved in the regulation of the release of neurotransmitters such as dopamine and GABA, which are important for various signaling pathways in the brain.

In addition to its role in signaling pathways, SLC39A4 is also a protein that is involved in the regulation of various cellular processes that are important for the development and maintenance of tissues in the body. This includes the regulation of cell cycle progression, cell death, and the regulation of cellular signaling pathways that are important for the development and maintenance of tissues in the body.

Given its unique structure and the various roles that SLC39A4 is involved in, it is a protein that has the potential to be a drug target or biomarker. Researchers have shown that SLC39A4 can be targeted by small molecules such as inhibitors, which could be used to treat various diseases. For example, SLC39A4 has been shown to be involved in the regulation of neurotransmitter release and the regulation of synaptic plasticity, which makes it a potential target for treating various neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, and depression.

In conclusion, SLC39A4 is a transmembrane protein that is involved in various physiological processes in the body. Its unique structure and the various roles that it is involved in make it a potential drug target or biomarker. Further research is needed to fully understand the role of SLC39A4 in the regulation of various physiological processes in the body and to explore its potential as a drug target or biomarker.

Protein Name: Solute Carrier Family 39 Member 4

Functions: Plays an important role in cellular zinc homeostasis as a zinc transporter. Regulated in response to zinc availability (By similarity)

More Common Targets

SLC39A5 | SLC39A6 | SLC39A7 | SLC39A8 | SLC39A9 | SLC3A1 | SLC3A2 | SLC40A1 | SLC41A1 | SLC41A2 | SLC41A3 | SLC43A1 | SLC43A2 | SLC43A3 | SLC44A1 | SLC44A2 | SLC44A3 | SLC44A3-AS1 | SLC44A4 | SLC44A5 | SLC45A1 | SLC45A2 | SLC45A3 | SLC45A4 | SLC46A1 | SLC46A2 | SLC46A3 | SLC47A1 | SLC47A1P2 | SLC47A2 | SLC48A1 | SLC49A3 | SLC49A4 | SLC4A1 | SLC4A10 | SLC4A11 | SLC4A1AP | SLC4A2 | SLC4A3 | SLC4A4 | SLC4A5 | SLC4A7 | SLC4A8 | SLC4A9 | SLC50A1 | SLC51A | SLC51B | SLC52A1 | SLC52A2 | SLC52A3 | SLC5A1 | SLC5A10 | SLC5A11 | SLC5A12 | SLC5A2 | SLC5A3 | SLC5A4 | SLC5A4-AS1 | SLC5A5 | SLC5A6 | SLC5A7 | SLC5A8 | SLC5A9 | SLC66A1 | SLC66A1L | SLC66A2 | SLC66A3 | SLC6A1 | SLC6A1-AS1 | SLC6A10P | SLC6A10PB | SLC6A11 | SLC6A12 | SLC6A13 | SLC6A14 | SLC6A15 | SLC6A16 | SLC6A17 | SLC6A18 | SLC6A19 | SLC6A2 | SLC6A20 | SLC6A3 | SLC6A4 | SLC6A5 | SLC6A6 | SLC6A7 | SLC6A8 | SLC6A9 | SLC7A1 | SLC7A10 | SLC7A11 | SLC7A11-AS1 | SLC7A13 | SLC7A14 | SLC7A2 | SLC7A3 | SLC7A4 | SLC7A5 | SLC7A5P1